HOOKIPA Pharma Inc. (NASDAQ:HOOK) Q4 2022 Earnings Call Transcript
Operator: Good morning and thank you for joining the HOOKIPA Pharma Fourth Quarter and Full Year 2022 Earnings and 2022 Outlook Conference Call.
Hookipa Pharma Inc. (HOOK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 812,814 | $877,839 | 0.01% | |
| 2. | Siren L.L.C. Raymond Debbane | 566,640 | $611,971 | 0.03% | |
| 3. | Knoll Capital Management Fred Knoll | 498,625 | $538,515 | 0.35% | |
| 4. | Ikarian Capital Neil Shahrestani | 52,996 | $57,236 | 0.01% | |
| 5. | Renaissance Technologies Jim Simons | 40,970 | $44,248 | +21% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| Officer, Director | $0.73 | 7,000 | $5,075.00 | 43,092 | 2023-08-21 | Filing |
| Officer, Director | $0.71 | 8,000 | $5,712.00 | 36,092 | 2023-08-16 | Filing |
| Officer, Director | $0.83 | 5,000 | $4,142.00 | 71,952 | 2023-07-11 | Filing |
| Officer, Director | $0.81 | 5,000 | $4,050.00 | 66,952 | 2023-07-07 | Filing |
| Officer, Director | $0.89 | 5,000 | $4,450.00 | 61,952 | 2023-07-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| Officer | $2.49 | 2,205 | $5,490.45 | 85,307 | 2021-12-21 | Filing |
| Officer | $2.49 | 7,440 | $18,525.60 | 84,104 | 2021-12-21 | Filing |
| Officer | $2.49 | 5,304 | $13,206.96 | 80,178 | 2021-12-21 | Filing |
| Large Shareholder | $11.60 | 328,620 | $3,812,386.34 | 3,177,574 | 2021-04-21 | Filing |
| Large Shareholder | $13.67 | 36,829 | $503,570.28 | 3,506,194 | 2021-03-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,875,945 | $2,026,021 | 0.17% | |
| 2. | 349,767 | $377,749 | 0% | |
| 3. | 300,819 | $324,884 | 0% | |
| 4. | 73,432 | $79,330 | 0% | |
| 5. | 31,054 | $33,538 | 0% |
News See All
15 Most Advanced Countries in Europe
Over the course of recent human history, Europe has proven to be the bedrock of innovation.
12 Penny Stocks With Biggest Upside
Even though the United States economy has been rattled by recession fears in the past few months, there are reasons to be optimistic about the near-term future of the market.
5 Best High Volume Penny Stocks to Buy Now
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United...
10 Best Medical Stocks Under $5
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the ...
Is HOOK A Good Stock To Buy Now?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money managers and analyze their...
Hedge Funds Are Selling HOOKIPA Pharma Inc. (HOOK)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On HOOKIPA Pharma Inc. (HOOK)
Is HOOKIPA Pharma Inc.